trial · primary record
Enzalutamide
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-04-30 |
| Primary endpoint | Progression free survival (PFS) |
| Registry ID | NCT04015622 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:35.394Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04015622
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.